WYDASE INJECTION LIQ 150 UNITS/ML
WYDASE INJECTION LIQ 150 UNITS/ML
Discontinued
DIN Number
02041278
Drug Class
Human
Market Date
Dec 31, 1994
Company
HC
wyeth-ayerst canada inc.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02041278
AIG Number0107586001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
B06AA03 HYALURONIDASE
Product Specifications
Dosage FormLiquid
Route of AdministrationBlock/Infiltration
,
Subcutaneous
AHFS Classification44:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
HYALURONIDASEActive
Strength: 150 UNIT / ML
Monograph: HYALURONIDASE